Marvel Biosciences Corp.
MRVL.V
TSX
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -62.80% | 77.71% | -90.48% | -73.79% | -40.86% |
| Total Receivables | 44.34% | -16.96% | 21.85% | 34.33% | 34.67% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.34% | -1.89% | -24.69% | -18.78% | -16.73% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -33.62% | 43.33% | -71.52% | -47.57% | -30.42% |
|
|
|||||
| Total Current Assets | -33.62% | 43.33% | -71.52% | -47.57% | -30.42% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -33.62% | 43.33% | -71.52% | -47.57% | -30.42% |
|
|
|||||
| Total Accounts Payable | 11.10% | -1.48% | 7.30% | -12.21% | 6.22% |
| Total Accrued Expenses | 101.23% | 61.99% | 77.27% | 86.26% | 34.17% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 34.83% | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 30.38% | 68.38% | 14.10% | -4.06% | 126.85% |
|
|
|||||
| Total Current Liabilities | 30.38% | 68.38% | 14.10% | -4.06% | 126.85% |
| Long-Term Debt | -- | -52.92% | 5.38% | 70.43% | 62.84% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 30.38% | 9.77% | 9.97% | 23.91% | 32.03% |
|
|
|||||
| Common Stock & APIC | 11.48% | 14.10% | -4.58% | 2.93% | 1.27% |
| Retained Earnings | -20.44% | -15.34% | -8.12% | -14.36% | -12.59% |
| Treasury Stock & Other | 48.95% | -- | -- | -- | 38.78% |
| Total Common Equity | -41.51% | -5.54% | -33.58% | -37.85% | -56.45% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -41.51% | -5.54% | -33.58% | -37.85% | -56.45% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -41.51% | -5.54% | -33.58% | -37.85% | -56.45% |
|
|
|||||